The revenue change in the 'In Vitro Diagnostics' segment of the medical technology market in the United States was forecast to continuously increase between 2024 and 2029 by in total 4.2 percentage points. According to this forecast, in 2029, the revenue change will have increased for the sixth consecutive year to 3.36 percent.
Data provided by Statista Market Insights are estimates.
Definition: The market In Vitro Diagnostics (IVD) consists of medical instruments and accessories used to perform tests with the help of biological samples. In Vitro Diagnostics provide valuable information used for detection, prognosis, prevention, and therapeutic monitoring of diseases.
Additional information: Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.
Company examples: Roche Diagnostics, Abbott Laboratories, Danaher, Siemens Healthineers. Further information on the key players can be found in the Market Shares boxes.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Statista. (August 29, 2024). Revenue growth of in vitro diagnostics in the U.S. 2019-2029 [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1369711/united-states-ivd-revenue-change
Statista. "Revenue growth of in vitro diagnostics in the U.S. 2019-2029." Chart. August 29, 2024. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1369711/united-states-ivd-revenue-change
Statista. (2024). Revenue growth of in vitro diagnostics in the U.S. 2019-2029. Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1369711/united-states-ivd-revenue-change
Statista. "Revenue Growth of in Vitro Diagnostics in The U.S. 2019-2029." Statista, Statista Inc., 29 Aug 2024, https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1369711/united-states-ivd-revenue-change
Statista, Revenue growth of in vitro diagnostics in the U.S. 2019-2029 Statista, https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1369711/united-states-ivd-revenue-change (last visited November 10, 2024)
Revenue growth of in vitro diagnostics in the U.S. 2019-2029 [Graph], Statista, August 29, 2024. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1369711/united-states-ivd-revenue-change